Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer.
Rowe, Peter C, Underhill, Rosemary A, Friedman, Kenneth J et al. · Frontiers in pediatrics · 2017 · DOI
Quick Summary
This guide helps doctors understand and diagnose ME/CFS in children and teenagers. ME/CFS causes extreme tiredness and makes it hard for young people to do physical or mental activities—with symptoms often getting worse after even small efforts and lasting for days or longer. The guide explains that there is no single test for ME/CFS, so doctors must diagnose it based on symptoms and by ruling out other conditions, and recommends that treatment focus on finding the right balance between rest and activity.
Why It Matters
This is one of the first comprehensive clinical primers addressing the diagnostic and management challenges specific to children and adolescents with ME/CFS, a population often overlooked in medical education and research. Early and accurate diagnosis can prevent years of misdiagnosis and unnecessary testing, while evidence-based management guidance helps clinicians prevent symptom exacerbation and improve quality of life in young patients.
Observed Findings
Pediatric ME/CFS prevalence estimates range from 0.1 to 0.5% in young populations.
Many young patients experience symptoms for years before receiving a diagnosis.
Disease severity ranges widely, from partial school attendance to wheelchair dependence, housebound status, or bedbound states.
Post-exertional symptom worsening can persist for hours, days, or weeks and is not relieved by rest or sleep.
Co-existing conditions such as orthostatic intolerance are commonly observed in pediatric ME/CFS.
Inferred Conclusions
Clinical diagnosis of pediatric ME/CFS is based on characteristic symptoms and exclusion of other fatiguing illnesses, as no diagnostic biomarker currently exists.
Successful management requires individualizing the balance of rest and activity to prevent post-exertional symptom worsening.
Healthcare providers often lack essential knowledge needed for timely diagnosis and appropriate management of ME/CFS in young patients.
Multisystem involvement and variable disease severity require comprehensive assessment and symptom-specific treatment approaches.
Remaining Questions
What are the biological mechanisms and etiology underlying ME/CFS in children and adolescents?
What This Study Does Not Prove
This primer does not establish the underlying cause or etiology of ME/CFS, nor does it present new experimental data or clinical trial results. It is a consensus-based guideline rather than a research study with hypothesis testing, so it cannot prove causal relationships between interventions and outcomes, only synthesize existing clinical knowledge and expert experience.